s u m m a r y a r t i c l e i n f o Objectives: To evaluate whether augmenting neuronal protective mechanisms might slow or arrest experimental diabetic peripheral neuropathy (DPN). DPN is one of the most common neurodegenerative disorders and is rising in prevalence. How it targets sensory neurons is uncertain; the disorder is irreversible and untreatable. We explored the intrinsic protective properties of overexpressed human HSP27 on experimental DPN. HSP27 is a small pro-survival heat shock protein that also increases axonal regeneration. Methods: Experimental diabetes was superimposed on mice overexpressing a human HSP27 transgene and its impact was evaluated on epidermal innervation, behavioral tests of sensation and electrophysiological indices of DPN. Results: Mice that overexpress human HSP27 in their sensory and motor neurons and that were made diabetic for 6 months by streptozotocin treatment were protected from a range of neuropathic abnormalities, including loss of footpad thermal sensation, mechanical allodynia, loss of epidermal innervation, and slowing of sensory conduction velocity. The protection was selective for sensory neurons in comparison to motor neurons and at 6 months provided better protection in female than male mice. Markers of RAGE-NFκB activation were attenuated by the transgene. Conclusions: The findings support the idea that diabetic polyneuropathy involves a unique, sensory-centric neurodegenerative process which can be reduced by overexpressing a single gene, an important starting point for new disease-modifying therapeutic approaches.
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Diabetic polyneuropathy (DPN) may be among the most common neurodegenerative disorders, involving approximately 50% of all persons with diabetes mellitus, now ranked at 6-10% of the global population and rising in prevalence (Wild et al., 2004; Yang et al., 2010) . The mechanisms of DPN remain uncertain and the disorder is currently irreversible. Roles for excessive polyol flux, nerve microangiopathy, impaired growth factor availability and free radical stress, among others, have all been considered (Obrosova, 2009; Tomlinson, 2008; Zochodne, 2007) . While controversial, a common thread among these ideas is that there is neuronal targeting by a unique and gradual neurodegenerative cascade that involves sensory neurons early. If correct, an approach that augments intrinsic survival pathways would prevent the range of abnormalities that develop during neuropathy in the peripheral nervous system.
Heat shock proteins (HSPs) are candidates for protecting sensory neurons from neurotoxic insults. As inducible molecular chaperones, they assist in the proper folding and assembly of nascent polypeptides and help to target abnormal proteins for lysosomal degradation (Ohtsuka and Suzuki, 2000) . HSPs provide constitutive protection to peripheral neurons, since HSP27 gene mutations, for example, are associated with inherited forms of polyneuropathy (Houlden et al., 2008) . An association between the presence of polyneuropathy and circulating HSP27 has also been identified in a large cohort of human subjects with type 1 diabetes mellitus (Gruden et al., 2008) . HSP27 expression promotes survival of adult sensory and motor neurons after axonal injury, and its expression is elevated in sensory neurons of diabetic rodent models (Benn et al., 2002; Zochodne et al., 2001) . HSP27 (or its mouse analog, HSP25) knockdown or overexpression are respectively associated with attenuated or improved axon regeneration in adult sensory neurons (Lewis et al., 1999; Ma et al., 2011) .
We hypothesized that overexpression of a human transgene of HSP27 in mice rendered Type 1 diabetic with streptozotocin (STZ) might protect peripheral neurons from progressive degeneration. The findings identified an interesting form of apparent selective sensory neuron protection over a range of behavioral, electrophysiological, structural and molecular neuropathic abnormalities.
Methods

Human HSP27 transgenic mice and breeding
Mice overexpressing hHSP27 were generated in the Woolf lab by microinjecting the prepared transgenic construct into fertilized B6C3F1 Neurobiology of Disease 47 (2012) [436] [437] [438] [439] [440] [441] [442] [443] 
